Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 89.58% is 84% above its 5-year average of 48.69%, near the high end of its 5-year range (-90.07%–93.84%).
3.30% above its 12-month average of 86.72%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 63.26%.
GROSS MARGIN
89.58%
GROSS MARGIN AVG TTM
86.72%
GROSS MARGIN AVG 3Y
87.90%
GROSS MARGIN AVG 5Y
48.69%
GROSS MARGIN AVG 10Y
54.52%
GROSS MARGIN AVG 15Y
62.29%
GROSS MARGIN AVG 20Y
61.55%
CURRENT VS TTM AVG
+3.30%
CURRENT VS 3Y AVG
+1.91%
CURRENT VS 5Y AVG
+83.97%
CURRENT VS 10Y AVG
+64.31%
CURRENT VS 15Y AVG
+43.81%
CURRENT VS 20Y AVG
+45.55%
SECTOR MEDIAN · HEALTHCARE
41.76%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
+114.51%
vs the sector median at left
Market Cap
$11.24M
Gross Margin
N/A
TTM Avg
-101.19%
3Y Avg
-33.23%
5Y Avg
-22.16%
Market Cap
$11.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$11.26M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
25.00%
5Y Avg
-4489.78%
Market Cap
$11.46M
Gross Margin
18.76%
TTM Avg
9.38%
3Y Avg
50.69%
5Y Avg
33.79%
Market Cap
$11.38M
Gross Margin
14.12%
TTM Avg
57.06%
3Y Avg
28.53%
5Y Avg
19.02%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerenome, Inc. (CNSY) | $10.81M | 89.58% | 86.72% | 87.90% | 48.69% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.24M | N/A | -101.19% | -33.23% | -22.16% |
| BioVie Inc. (BIVI)vs › | $11.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Biofrontera Inc. (BFRI)vs › | $11.14M | 84.45% | 64.39% | 56.15% | 53.94% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.26M | 0.00% | 50.00% | 25.00% | -4489.78% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.46M | 18.76% | 9.38% | 50.69% | 33.79% |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.38M | 14.12% | 57.06% | 28.53% | 19.02% |
| Lifeward Ltd. (LFWD)vs › | $10.47M | 35.95% | 35.13% | 34.24% | 39.24% |
| Satellos Bioscience Inc. (MSLE)vs › | $10.42M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
89.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 63.26% |
| 2026-03-31 | 89.40% |
| 2025-12-31 | 93.27% |
| 2025-09-30 | 93.84% |
| 2025-06-30 | 93.81% |
| 2025-03-31 | 82.91% |
| 2024-12-31 | 83.57% |
| 2024-09-30 | 84.07% |
| 2024-06-30 | 84.21% |
| 2024-03-31 | 88.91% |
| 2023-12-31 | 86.14% |
| 2023-09-30 | 84.84% |
| 2023-06-30 | 89.86% |
| 2023-03-31 | 63.04% |
| 2022-12-31 | -90.07% |
| 2022-09-30 | -68.49% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | -45.54% |
| 2019-09-30 | 80.70% |
| 2019-06-30 | -326.82% |
| 2019-03-31 | 75.49% |
| 2018-12-31 | 89.23% |
| 2018-09-30 | 75.46% |
| 2018-06-30 | 79.22% |
| 2018-03-31 | 83.43% |
| 2017-12-31 | 78.66% |
| 2017-09-30 | 89.79% |
| 2017-06-30 | 52.87% |
| 2017-03-31 | 74.52% |
| 2016-12-31 | 68.78% |
| 2016-09-30 | 76.32% |
| 2016-06-30 | 79.29% |
| 2016-03-31 | 80.57% |
| 2015-12-31 | 76.57% |
| 2015-09-30 | 79.73% |
| 2015-06-30 | 62.55% |
| 2015-03-31 | 74.51% |
| 2014-12-31 | -17.14% |
| 2014-09-30 | 69.45% |
| 2014-06-30 | 40.67% |
| 2014-03-31 | 70.64% |
| 2013-12-31 | 67.49% |
| 2013-09-30 | 65.66% |
| 2013-06-30 | 73.18% |
| 2013-03-31 | 79.88% |
| 2012-12-31 | 80.73% |
| 2012-09-30 | 46.58% |
| 2012-06-30 | 76.42% |
| 2012-03-31 | 42.52% |
| 2011-12-31 | -14.42% |
| 2011-09-30 | 55.96% |
| 2011-06-30 | 54.21% |
| 2011-03-31 | 67.58% |
| 2010-12-31 | 55.31% |
| 2010-09-30 | 41.92% |
| 2010-06-30 | 57.91% |
| 2010-03-31 | 78.91% |
| 2009-12-31 | 73.97% |
| 2009-09-30 | 43.58% |
| 2009-06-30 | 90.91% |
| 2009-03-31 | 43.39% |
| 2008-12-31 | 373.84% |
| 2008-09-30 | 72.07% |
| 2008-06-30 | 51.92% |
| 2008-03-31 | 60.78% |
| 2007-12-31 | -1756475.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | 61.52% |
| 2007-03-31 | 19.64% |
| 2006-12-31 | 95.72% |
| 2006-09-30 | -187.97% |
| 2006-06-30 | -11.26% |
| 2006-03-31 | 9.56% |
| 2005-12-31 | -2.91% |
| 2005-09-30 | 41.34% |
| 2005-06-30 | 50.10% |
| 2005-03-31 | 57.55% |
| 2004-12-31 | 33.42% |
| 2004-09-30 | 33.26% |
| 2004-06-30 | 79.61% |
| 2004-03-31 | 52.42% |
| 2003-12-31 | 71.01% |
| 2003-09-30 | 68.01% |
| 2003-06-30 | 72.89% |
| 2003-03-31 | 66.87% |
| 2002-12-31 | 134.59% |
| 2002-09-30 | 28.95% |
